• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SeqLL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    11/9/23 4:59:16 PM ET
    $SQL
    Medical Specialities
    Health Care
    Get the next $SQL alert in real time by email
    0001605888 false 0001605888 2023-11-03 2023-11-03 0001605888 SQL:CommonStockParValue.00001PerShareMember 2023-11-03 2023-11-03 0001605888 SQL:WarrantsToPurchaseCommonStockMember 2023-11-03 2023-11-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) November 3, 2023

     

    SEQLL INC.

    (Exact name of registrant as specified in charter)

     

    Delaware   001-40760   46-5319744
    (State or other Jurisdiction of
    Incorporation or Organization)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    3 Federal Street

    Billerica, MA

      01821
    (Address of Principal Executive Offices)   (zip code)

     

    (781) 460-6016

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $.00001 per share   SQL   The Nasdaq Market LLC
    Warrants to purchase Common Stock   SQLLW   The Nasdaq Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

     

     

     

     

     

      

    Item 1.01 Entry Into a Material Definitive Agreement.

     

    Amendment No. 4 to the Merger Agreement

     

    As previously reported, on May 29, 2023, SeqLL, Inc., a Delaware corporation (the “Company”), SeqLL Merger LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (“Purchaser Sub”), Atlantic Acquisition Corp, a Delaware corporation (“Atlantic”), Atlantic Merger LLC, a Delaware limited liability company and a majority-owned subsidiary of Atlantic (“Atlantic Merger Sub”), Lyneer Investments, LLC, a Delaware limited liability company (“Lyneer”), IDC Technologies, Inc., a California corporation (“IDC”), and Lyneer Management Holdings LLC, a Delaware limited liability company (“Lyneer Management”), entered into an Agreement and Plan of Reorganization, as amended on June 23, 2023, on October 5, 2023, and on October 17, 2023 (the “Merger Agreement”), pursuant to which (i) Atlantic Merger Sub will be merged with and into Lyneer, with Lyneer continuing as the surviving entity (the “Lyneer Merger”), and (ii) Purchaser Sub will subsequently be merged with and into Lyneer, with Lyneer continuing as the surviving entity and as a wholly-owned subsidiary of the Company (the “SeqLL Merger” and, together with the Lyneer Merger, the “Mergers”).

     

    On November 3, 2023, the Company entered into Amendment No. 4 to the Agreement and Plan of Reorganization (the “Amendment”) with the other parties thereto. Prior to the Amendment, as consideration for the acquisition by the Company of Lyneer in the Mergers, the Company was to (i) pay to IDC and Lyneer Management an aggregate of $35,000,000 in cash (the “Cash Consideration”) and (ii) issue to (a) IDC and Lyneer Management a number of shares of the Company’s common stock (the “Lyneer Stock Consideration”) equal to the quotient of $55,000,000 divided by the price per share (the “Offering Price”) at which the Company’s common stock is sold in the Capital Raise (as defined in the Merger Agreement) , of which 90% percent of such shares will be issued to IDC and 10% percent of such shares will be issued to Lyneer Management and (b) Atlantic a number of shares of the Company’s common stock (the “Atlantic Stock Consideration”) to be determined based upon the following formula:

     

    (A/B) – [(C/B) + D]

     

    Where:

    A= $150,000,000

    B= the Offering Price

    C= $67,000,000

    D= number of shares of the Company’s common stock sold in the Capital Raise

    (exclusive of shares issued in respect of any over-allotment option).

     

    The Amendment amends (i) the Lyneer Stock Consideration such that 90% of the shares that were previously issuable to IDC shall now be issuable at the direction of IDC to Prateek Gattani,,the Chief Executive Officer and principal stockholder of IDC and the Chairman of the Board of the Company following the Mergers, (ii) the Atlantic Stock Consideration to be a number of shares of the Company’s common stock equal to the quotient of $43,000,000 divided by the Offering Price, and (iii) the Cash Consideration such that $20,000,000 of the aggregate $35,000,000 of Cash Consideration payable to IDC and Lyneer Management shall now be paid in the form of a convertible promissory note in the principal amount of $20,000,000 (the “Merger Note”), which shall be issued to IDC. The Merger Note will not bear interest and will not be convertible prior to an event of default under the Merger Note. If an event of default should occur under the Merger Note, the Merger Note will bear interest at the rate of 7% per annum commencing upon the date of such event of default and will be convertible into shares of the Company’s common stock at a price per share that equals then-current market prices, but not less than 80% of the price per share at which the Company’s common stock is sold in the Capital Raise. If the Merger Note is convertible into shares of the Company’s common stock, IDC would have demand and incidental registration rights with respect to such shares.

     

    Additionally, prior to the Amendment, in connection with the consummation of the Mergers, the Company was required to declare (i) a cash dividend payable to its stockholders of record as of April 26, 2023 (the “Record Date”) in an amount equal to the Company’s cash and cash equivalents as of the closing date of the SeqLL Merger (exclusive of any proceeds of the Capital Raise), less any amounts withheld for taxes and certain other obligations as of such date and (ii) a stock dividend issuable to such stockholders of an aggregate of 819,352 shares of the Company’s common stock, assuming a public offering price of $10.00 per share in the Capital Raise. The Amendment removes the requirement for the declaration of such dividends in consideration of the Company’s agreement to make a settlement offer within 90 days of the closing of the Mergers to its stockholders of record as of the Record Date for such dividends to settle any claims for failing to pay such dividends by issuing to such stockholders the amount of cash and the number of shares of the Company’s common stock that such stockholders would have received had such dividends been declared and made.

     

    1

     

     

    The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the Amendment, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K. Unless otherwise defined herein, the capitalized terms used above are defined in the Merger Agreement.

     

    The foregoing summary of the Merger Agreement and the Amendment have been included to provide investors and securityholders with information regarding the terms of the Merger Agreement, as amended by the Amendment, and is qualified in its entirety by the terms and conditions of the Merger Agreement, as amended. It is not intended to provide any other factual information about the Company, Atlantic, Lyneer or their respective subsidiaries and affiliates. The representations, warranties and covenants contained in the Merger Agreement, as amended, were made only for purposes of such agreement and as of specified dates, were solely for the benefit of the respective parties to such agreement, may be subject to limitations agreed upon by the contracting parties, and may be subject to standards of materiality that differ from those applicable to investors. Moreover, certain representations and warranties in the Merger Agreement, as amended, may have been used for the purpose of allocating risk between the parties rather than establishing matters of fact. Accordingly, investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Atlantic, Lyneer, Lyneer Management or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures.

     

    Item 7.01 Regulation FD Disclosure

     

    Forward-Looking Statements

     

    The information included herein and in any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of present or historical fact included herein, regarding the transactions described herein (the “Transactions”), the Company’s ability to consummate the Transactions and raise capital prior to the Mergers, the benefits of the Transactions, the Company’s future financial performance following the Transactions, as well as the Company’s and Atlantic’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used herein, including any oral statements made in connection herewith, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company, Atlantic and Lyneer’s management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date hereof. The Company cautions you that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. These risks include, but are not limited to, general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the inability of the parties to successfully or timely consummate the Transactions or to satisfy the closing conditions, including the closing of the Capital Raise; the failure to realize the anticipated benefits of the Transactions, including as a result of a delay in its consummation; the occurrence of events that may give rise to a right of one or all of the Company, Atlantic and Lyneer to terminate the definitive agreements related to the Transactions; the risks related to the growth of the Company’s business and the timing of expected business milestones; and the effects of competition on the Company’s future business. Should one or more of the risks or uncertainties described herein and in any oral statements made in connection therewith occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. There may be additional risks that neither the Company, Atlantic or Lyneer presently know or that the Company, Atlantic and Lyneer currently believe are immaterial that could cause actual results to differ from those contained in the forward-looking statements. Additional information concerning these and other factors that may impact the Company’s expectations can be found in the Company’s periodic filings with the SEC, including the Company’s Annual Report on Form 10-K filed with the SEC on March 16, 2023 and any subsequently filed Quarterly Report on Form 10-Q. The Company’s SEC filings are available publicly on the SEC’s website at www.sec.gov.

     

    2

     

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    See the Exhibit Index below, which is incorporated by reference herein.

     

    Exhibit No.   Description
    2.1*   Amendment No. 4 to Agreement and Plan of Reorganization dated as of November 3, 2023 among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp, Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. (incorporated by reference to Exhibit 2.5 of the Company’s Registration Statement on Form S-1/A dated November 7, 2023)
    104   Cover Page Interactive Data File (the cover page XBRL tags are embedded in the inline XBRL document)

     

    * Schedules, exhibits and similar supporting attachments to this exhibit are omitted pursuant to Item 601(b)(2) of Regulation S-K. We agree to furnish a supplemental copy of any omitted schedule or similar attachment to the Securities and Exchange Commission upon request.

     

    3

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 9, 2023 SEQLL INC.
         
      By: /s/ Daniel Jones
        Daniel Jones
        Chief Executive Officer

     

    4

    Get the next $SQL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SQL

    DatePrice TargetRatingAnalyst
    2/9/2022$3.00Buy
    Maxim Group
    More analyst ratings

    $SQL
    SEC Filings

    View All

    SEC Form EFFECT filed by SeqLL Inc.

    EFFECT - SeqLL, Inc. (0001605888) (Filer)

    2/13/24 12:15:19 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form S-1/A filed by SeqLL Inc. (Amendment)

    S-1/A - SeqLL, Inc. (0001605888) (Filer)

    2/12/24 3:01:45 PM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form S-1/A filed by SeqLL Inc. (Amendment)

    S-1/A - SeqLL, Inc. (0001605888) (Filer)

    2/9/24 5:23:38 PM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on SeqLL with a new price target

    Maxim Group initiated coverage of SeqLL with a rating of Buy and set a new price target of $3.00

    2/9/22 8:40:22 AM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Pfeffer David bought $20,163 worth of shares (20,000 units at $1.01), increasing direct ownership by 22% to 20,000 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:37:35 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form 4: Milos Patrice M. bought $10,088 worth of shares (10,000 units at $1.01), increasing direct ownership by 14% to 10,000 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:37:03 AM ET
    $SQL
    Medical Specialities
    Health Care

    SEC Form 4: Jones Daniel Robert bought $2,236 worth of shares (5,733 units at $0.39), increasing direct ownership by 0.24% to 2,392,365 units (Amendment)

    4/A - SeqLL, Inc. (0001605888) (Issuer)

    1/30/23 11:36:38 AM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Financials

    Live finance-specific insights

    View All

    Atlantic International Corp. Acquires Lyneer Staffing Solutions

    ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

    6/21/24 7:00:00 AM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

    BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

    10/30/23 4:30:00 PM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Inc. Enters into a Definitive Merger Agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.

    BILLERICA, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), a technology company providing life sciences instrumentation and research services, today announced that it has entered into a definitive merger agreement (the "Merger Agreement") with Lyneer Investments, LLC ("Lyneer"), the indirect parent company of Lyneer Staffing Solutions, LLC and Atlantic Acquisition Corp. ("Atlantic"), and related parties, pursuant to which Lyneer will become a wholly-owned subsidiary of SeqLL. Under the terms of the Merger Agreement, SeqLL will pay $60,000,000 in cash to the Lyneer members, and issue to the Lyneer members and Atlantic, an aggregate o

    5/30/23 8:30:00 AM ET
    $SQL
    Medical Specialities
    Health Care

    $SQL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp. Acquires Lyneer Staffing Solutions

    ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

    6/21/24 7:00:00 AM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

    BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

    10/30/23 4:30:00 PM ET
    $SQL
    Medical Specialities
    Health Care

    SeqLL Announces Cash and Stock Dividend Record Date

    BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), announced today that its board of directors has set September 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the Agreement and Plan of Reorganization dated as of May 29, 2023, as amended (the "Merger Agreement"), by and among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp., Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. The dividend distribution of shares of common stock of the Company and the cash dividend will

    9/15/23 5:24:58 PM ET
    $SQL
    Medical Specialities
    Health Care